NCT00297180View on ClinicalTrials.gov

Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks

PHASE2CompletedINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

Obesity

Interventions

DRUG

GW869682

Trial Locations (3)

32114

GSK Investigational Site, Daytona Beach

70808

GSK Investigational Site, Baton Rouge

97239

GSK Investigational Site, Portland

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY